| Joel Stuart Solomon, MD | |
|
3303 Sw Bond Ave, Mail Code Ch5p, Portland, OR 97239-4501 | |
| (503) 494-6687 | |
| (503) 494-1717 |
| Full Name | Joel Stuart Solomon |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 31 Years |
| Location | 3303 Sw Bond Ave, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770599227 | NPI | - | NPPES |
| 022971 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | MD25574 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
News Archive
With Thursday's Supreme Court ruling upholding the health law, debate has shifted to whether deadlines key to the law's goal of expanding coverage to tens of millions of Americans will be pushed back. Some say states and the federal government are facing such complex technical and political realities that there will be a need to push back some deadlines, including the Jan. 1, 2014, opening of new online marketplaces where individuals and small business will shop for coverage.
A new drug for lupus has won U.S. approval. The drug, Benlysta from Human Genome Sciences Inc., is administered once a month intravenously.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a regulatory update on Zalviso (sufentanil sublingual tablet system) intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Visits to the doctor for a respiratory tract infection can lead to unnecessary antibiotic prescribing, but an online intervention with real-time information on locally circulating viruses may reduce mothers' intentions to visit their primary care doctor.
The deal, part of an agreement to allow Partners HealthCare System to acquire South Shore Hospital, would resolve an antitrust investigation and require Partners to pay for both an investigation into its practices and a court-appointed monitor.
› Verified 6 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
With Thursday's Supreme Court ruling upholding the health law, debate has shifted to whether deadlines key to the law's goal of expanding coverage to tens of millions of Americans will be pushed back. Some say states and the federal government are facing such complex technical and political realities that there will be a need to push back some deadlines, including the Jan. 1, 2014, opening of new online marketplaces where individuals and small business will shop for coverage.
A new drug for lupus has won U.S. approval. The drug, Benlysta from Human Genome Sciences Inc., is administered once a month intravenously.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a regulatory update on Zalviso (sufentanil sublingual tablet system) intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Visits to the doctor for a respiratory tract infection can lead to unnecessary antibiotic prescribing, but an online intervention with real-time information on locally circulating viruses may reduce mothers' intentions to visit their primary care doctor.
The deal, part of an agreement to allow Partners HealthCare System to acquire South Shore Hospital, would resolve an antitrust investigation and require Partners to pay for both an investigation into its practices and a court-appointed monitor.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Stuart Solomon, MD 3303 Sw Bond Ave, Mail Code Ch5p, Portland, OR 97239-4501 Ph: (503) 494-6687 | Joel Stuart Solomon, MD 3303 Sw Bond Ave, Mail Code Ch5p, Portland, OR 97239-4501 Ph: (503) 494-6687 |
News Archive
With Thursday's Supreme Court ruling upholding the health law, debate has shifted to whether deadlines key to the law's goal of expanding coverage to tens of millions of Americans will be pushed back. Some say states and the federal government are facing such complex technical and political realities that there will be a need to push back some deadlines, including the Jan. 1, 2014, opening of new online marketplaces where individuals and small business will shop for coverage.
A new drug for lupus has won U.S. approval. The drug, Benlysta from Human Genome Sciences Inc., is administered once a month intravenously.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a regulatory update on Zalviso (sufentanil sublingual tablet system) intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Visits to the doctor for a respiratory tract infection can lead to unnecessary antibiotic prescribing, but an online intervention with real-time information on locally circulating viruses may reduce mothers' intentions to visit their primary care doctor.
The deal, part of an agreement to allow Partners HealthCare System to acquire South Shore Hospital, would resolve an antitrust investigation and require Partners to pay for both an investigation into its practices and a court-appointed monitor.
› Verified 6 days ago
Dr. Michael F. Bohley, M.D.,P.C. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10201 Se Main St Ste 20, Portland, OR 97216 Phone: 503-253-3458 Fax: 503-253-0856 | |
Erik Matthew Wolfswinkel, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-6687 Fax: 503-494-1717 | |
Dr. Stiles Turner Jewett Jr., M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 12400 Nw Cornell Rd, Suite 200, Portland, OR 97229 Phone: 503-646-0101 Fax: 503-350-1420 | |
Michelle Bonapace-potvin, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3303 S Bond Ave Bldg 1, Portland, OR 97239 Phone: 150-349-4668 | |
Dr. Geoffrey Harry Buncke, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1040 Nw 22nd Ave, Suite 550, Portland, OR 97209 Phone: 503-973-5000 Fax: 503-274-0188 | |
Dr. Michael John Wheatley, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 N Graham St, Suite 330, Portland, OR 97227 Phone: 503-413-3650 Fax: 503-413-3644 | |
Reid Vance Mueller, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-6687 |